$44.53
0.08% today
Nasdaq, Apr 03, 06:46 pm CET
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Exact Sciences Corporation Stock price

$44.56
-2.99 6.29% 1M
-22.34 33.39% 6M
-11.63 20.70% YTD
-29.18 39.57% 1Y
-31.67 41.55% 3Y
-13.04 22.64% 5Y
+22.93 106.01% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
+1.11 2.55%
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Key metrics

Market capitalization $8.28b
Enterprise Value $10.01b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 134.34
EV/Sales (TTM) EV/Sales 3.63
P/S ratio (TTM) P/S ratio 3.00
P/B ratio (TTM) P/B ratio 3.44
Revenue growth (TTM) Revenue growth 10.37%
Revenue (TTM) Revenue $2.76b
EBIT (operating result TTM) EBIT $-200.38m
Free Cash Flow (TTM) Free Cash Flow $74.55m
Cash position $1.04b
EPS (TTM) EPS $-5.56
P/E forward negative
P/S forward 2.71
EV/Sales forward 3.28
Short interest 5.76%
Show more

Is Exact Sciences Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Exact Sciences Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Exact Sciences Corporation forecast:

26x Buy
90%
3x Hold
10%

Analyst Opinions

29 Analysts have issued a Exact Sciences Corporation forecast:

Buy
90%
Hold
10%

Financial data from Exact Sciences Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,759 2,759
10% 10%
100%
- Direct Costs 848 848
14% 14%
31%
1,911 1,911
9% 9%
69%
- Selling and Administrative Expenses 1,467 1,467
4% 4%
53%
- Research and Development Expense 429 429
1% 1%
16%
14 14
119% 119%
1%
- Depreciation and Amortization 215 215
6% 6%
8%
EBIT (Operating Income) EBIT -200 -200
34% 34%
-7%
Net Profit -1,029 -1,029
404% 404%
-37%

In millions USD.

Don't miss a Thing! We will send you all news about Exact Sciences Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exact Sciences Corporation Stock News

Neutral
Business Wire
2 days ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its first quarter 2025 financial results after the close of the U.S. financial markets on May 1, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financia...
Neutral
Business Wire
3 days ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening.
Positive
Seeking Alpha
17 days ago
Natera Inc. shows robust growth with high margins, a strong genetic testing portfolio, and a recent pullback offering an attractive entry point for investors.
More Exact Sciences Corporation News

Company Profile

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Head office United States
CEO Kevin Conroy
Employees 7,000
Founded 1995
Website www.exactsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today